Mostrar el registro sencillo

dc.contributor.authorCañamero, Lucíaes_ES
dc.contributor.authorBenito-Hernández, Adalbertoes_ES
dc.contributor.authorGonzález, Elenaes_ES
dc.contributor.authorEscagedo, Claraes_ES
dc.contributor.authorRodríguez-Vidriales, Maríaes_ES
dc.contributor.authorGarcía Saiz, María del Mares_ES
dc.contributor.authorValero San Cecilio, Rosalía Maríaes_ES
dc.contributor.authorBelmar Vega, Laraes_ES
dc.contributor.authorCos Cossio, María de los Ángeles de es_ES
dc.contributor.authorFrancia Gil, María Victoriaes_ES
dc.contributor.authorRuiz San Millán, Juan Carlos es_ES
dc.contributor.authorRodrigo Calabia, Emilio es_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2023-11-02T16:38:03Z
dc.date.available2023-11-02T16:38:03Z
dc.date.issued2023es_ES
dc.identifier.issn2227-9059es_ES
dc.identifier.urihttps://hdl.handle.net/10902/30448
dc.description.abstractMeasuring the non-pathogenic Torque Teno Virus (TTV) load allows assessing the net immunosuppressive state after kidney transplantation (KTx). Currently, it is not known how exposure to maintenance immunosuppression affects TTV load. We hypothesized that TTV load is associated with the exposure to mycophenolic acid (MPA) and tacrolimus. We performed a prospective study including 54 consecutive KTx. Blood TTV load was measured by an in-house PCR at months 1 and 3. Together with doses and trough blood levels of tacrolimus and MPA, we calculated the coefficient of variability (CV), time in therapeutic range (TTR) and concentration/dose ratio (C/D) of tacrolimus, and the MPA-area under the curve (AUC-MPA) at the third month. TTV load at the first and third month discriminated those patients at risk of developing opportunistic infections between months 1 and 3 (AUC-ROC 0.723, 95%CI 0.559-0.905, p = 0.023) and between months 3 and 6 (AUC-ROC 0.778, 95%CI 0.599-0.957, p = 0.028), respectively, but not those at risk of acute rejection. TTV load did not relate to mean tacrolimus blood level, CV, TTR, C/D and AUC-MPA. To conclude, although TTV is a useful marker of net immunosuppressive status after KTx, it is not related to exposure to maintenance immunosuppression.es_ES
dc.description.sponsorshipFunding: This research was funded by grants for Fondo de Investigaciones Sanitarias-ISCIII (PI20/01710) and RICORS (ISCIII RD21/0005/0010, “Financiado por la Unión Europea—NextGenerationEU,” Mecanismo para la Recuperación y la Resiliencia [MRR]). Acknowledgments: The authors are indebted to Consuelo Agüeros (Nephrology Research Laboratory, Hospital Marqués de Valdecilla-IDIVAL) for technician supportes_ES
dc.format.extent13 p.es_ES
dc.language.isoenges_ES
dc.publisherMDPI AGes_ES
dc.rightsAttribution 4.0 International*
dc.rights© 2023 by the authorses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceBiomedicines, 2023, 11, 1410es_ES
dc.subject.otherAcute rejectiones_ES
dc.subject.otherImmunosuppressiones_ES
dc.subject.otherInfectiones_ES
dc.subject.otherKidney transplantationes_ES
dc.subject.otherMonitoringes_ES
dc.subject.otherTorque Teno viruses_ES
dc.titleTorque teno virus load predicts opportunistic Infections after kidney transplantation but Is not associated with maintenance immunosuppression exposurees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.3390/biomedicines11051410es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International